Patients aged 18 years or older with histologically or cytologically confirmed stage IV squamous non-small-cell lung cancer , with an Eastern Cooperative Oncology Group ( ECOG ) performance status of 0-2 and adequate organ function and who had not received previous chemotherapy for their disease were eligible for inclusion .